An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence.

Pfizer

Status and phase: Completed; Phase 2

Conditions: Urinary Incontinence, Stress

Treatments: Drug: SS-RBX

Study type: Interventional

Funder types: Industry

Identifiers

NCT00138749

A6061023

Details and patient eligibility

About

A study designed to assess the efficacy, toleration and safety of SS-RBX for the treatment of stress urinary incontinence.

Sex: Female

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Clinically significant stress urinary incontinence

Exclusion criteria

• History or evidence of any relevant confounding urological or neurological disease

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind